bioRxiv · 10.1101/2025.07.11.664289
Estrogens protect bone mass by inhibiting NAD+ metabolism in osteoclasts
Abstract
Estrogens protect against bone loss by reducing osteoclast number and bone resorption, primarily via direct actions on osteoclast precursors. In these cells, estrogens attenuate RANKL-induced stimulation of mitochondrial complex I, which is crucial for ATP generation through NADH oxidation. NAD+ promotes redox reactions and activates NAD+-dependent enzymes, including the mitochondrial deacetylase SIRT3. However, the contribution of NAD+ to the skeletal effects of estrogens remains unknown. We show that NAD+ levels and SIRT3 activity are upregulated by RANKL and inhibited by 17{beta}-estradiol (E2) in mouse and human osteoclast precursors. Increasing NAD+ or the mitochondrial NAD+/NADH ratio reverses the inhibitory effects of E2 on SIRT3 activity and osteoclastogenesis in vitro. Deletion of Nampt, a key NAD salvage enzyme, reduces NAD+ and prevents bone loss in ovariectomized mice. Similarly, deletion of Sirt3 in osteoclast precursors mitigates estrogen deficiency-induced bone resorption. These findings indicate that suppression of NAD+ levels and mitochondrial redox metabolism by estrogens contributes to their anti-resorptive effects via inhibition of SIRT3.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Kim, H.-N., Marques-Carvalho, A., Adam, G. O., Chalke, A., Resende-Coelho, A., Reyes-Castro, O., Warren, A., Grilo, L., Chini, C. N., Stronach, B., Alturkmani, F., Ambrogini, E., Chini, E. N., Almeida, M.. 2025-07-16. Estrogens protect bone mass by inhibiting NAD+ metabolism in osteoclasts. https://doi.org/10.1101/2025.07.11.664289
Cite the original work for its findings. Save a collection to share your selection of sources.